NCBiotech News

Now is the best time to sign up for your flu shot, and this is the best place to do it. When you reserve a 10-minute “NC Big Shot" slot on the North Carolina Biotechnology Center’s website for the Tuesday, October 4 VaccinatioNCelebration, it’ll reserve your free ticket to participate in a milestone of medicine.

Growing demand for natural products by health-conscious consumers has prompted Gaia Herbs to begin a nearly $5 million expansion of its production facilities in Brevard.

SynShark is using early loan funding from NCBiotech to develop an environmentally sustainable method of harvesting a valuable shark oil called squalene from the leaves of genetically engineered tobacco plants.

North Carolina is one of the world’s leading centers for the manufacture of biologics, pharmaceuticals, vaccines, diagnostics, medical devices and related products.

Modern agriculture has come a long way since the days when farming was basically “fert ‘n’ dirt.” That became clear as 135 movers and shakers from the expanding world of agricultural biotechnology shared ideas, auditions and a jam-packed day at NCBiotech’s third annual Ag Biotech Entrepreneurial Showcase.

Liquidia Technologies, a Research Triangle Park company that’s turning its unique PRINT nanobiotechnology platform into a license to print money selling disease-fighting “stealth” weapons, has made another baby, Lq3, its second spin-out company.

The Jobs Networking event at the NC Biotech Center for the month of April was on Exploring Biomanufacturing

Flucelvax package photo, courtesy of Novartis.

Employees rolled up their sleeves at the $1 billion Novartis Holly Springs vaccine manufacturing facility this week and joined the global throngs marking a revolution in the fight against flu.

Medicago has successfully produced a Virus-Like Particle vaccine candidate for the H7N9 virus, responsible for the recent avian flu outbreak in China.

Pfizer announced today that it will invest an additional $500 million and add 300 more jobs to increase its newly completed gene therapy manufacturing capabilities at its 230-acre campus in Sanford, North Carolina.

Seqirus, the world’s second largest influenza vaccine company, has broken ground for a $9 million expansion of its massive manufacturing facility in Holly Springs.

Pfizer, the global pharmaceutical giant, will expand its vaccine-manufacturing plant in Sanford with a $100 million investment in gene therapy that will add 40 jobs to its workforce.

The billion-dollar cell culture Seqirus vaccine factory in Holly Springs has hit yet another milestone. The highly skilled workers at the sprawling factory southeast of Raleigh successfully produced the world’s first cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.

When a chorus of cheers accompanies announcements like the $1.85 billion Novo Nordisk expansion in Clayton, the echo is a reminder: it's a team effort.

Novo Nordisk, a key member of North Carolina’s globally significant biomanufacturing landscape, is adding a projected $1.85 billion expansion and doubling its workforce of 700 at its 22-year-old Clayton campus in Johnston County.